SML1630

Bendazac

≥98% (HPLC)

• Sinónimos: Bendazolic acid, [(1-Benzyl-1H-indazol-3-yl)oxy]acetic acid
• Fórmula empírica (notación de Hill): C₁₆H₁₄N₂O₃
• Número de CAS: 20187-55-7
• Peso molecular: 282.29
• EC Number: 243-569-2
• MDL number: MFCD00866158
• UNSPSC Code: 12352200
• PubChem Substance ID: 329825514
• NACRES: NA.77

Propiedades

• Quality Level: 200
• assay: ≥98% (HPLC)
• form: powder
• solubility: DMSO: soluble ≥1 mg/mL; methanol: soluble ≥1 mg/mL
• storage temp.: 2-8°C
• SMILES string: OC(COC1=NN(CC2=CC=CC=C2)C3=CC=CC=C31)=O
• InChI: 1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)
• InChI key: BYFMCKSPFYVMOU-UHFFFAOYSA-N
• Gene Information: human ... XDH(7498)

Descripción

Biochem/physiol Actions

Bendazac (or bendazolic acid) is a non-steroidal anti-inflammatory drug used for joint and muscular pain. Bendazac is an anti-denaturant drug for cataract and other condensation diseases. In addition, Bendazac has been used in studies related to potential treatment and pevention of ischemia and reperfusion syndromes, and was found to inhibit only reversible and irreversible xanthine oxidase.

Información de seguridad

• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3